The Bloc, a leading global health-native agency, is proud to announce the addition of four dynamic leaders. Aiming to reinforce the company's dedication to creative innovation and strategic depth, the ...

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

After disappointing trial results for cancer treatments, Mural Oncology announced Wednesday it is cutting 90% of its ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

As the months ticked by in his job search, Albert started to wonder if there was something wrong with him. He got advice on ...

Back in 2022, as the biotech industry’s boom was plateauing, the brash venture capitalist told executives at the biotechs he had invested in that they would be “insane” to pursue an initial ...

Tempest Therapeutics is laying off 21 full-time workers to retain just five, as the cash-strapped Bay Area biotech company plots its next move.

The Chinese biotechnology industry has increased with high annual average growth rates over the last few decades. The market potential of the Chinese biotechnology industry is enormous and ...

Nonetheless, given the continuous need for innovative medical treatments, irrespective of the state of the economy, the dynamic biotech industry will continue to grab investors’ interest despite ...